Streptococcus pneumoniae vaccine - Onconetix
Alternative Names: BWV-201; SJ 11 0001Latest Information Update: 28 Mar 2024
At a glance
- Originator St. Jude Childrens Research Hospital
- Developer Onconetix; St. Jude Childrens Research Hospital
- Class Attenuated vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute sinusitis; Otitis media; Pneumonia
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for preclinical development in Acute-sinusitis(In children, Prevention, In adults) in USA (Intranasal)
- 28 Mar 2024 No recent reports of development identified for preclinical development in Otitis-media(In children, Prevention, In adults) in USA (Intranasal)
- 28 Mar 2024 No recent reports of development identified for preclinical development in Pneumonia(In children, Prevention, In adults) in USA (Intranasal)